Pulmozyme (Genentech Inc) en es it fr

Pulmozyme (Genentech Inc) Brand names, Pulmozyme (Genentech Inc) Analogs

Pulmozyme (Genentech Inc) Brand Names Mixture

  • No information avaliable

Pulmozyme (Genentech Inc) Chemical_Formula

C1321H1999N339O396S9

Pulmozyme (Genentech Inc) RX_link

http://www.rxlist.com/cgi/generic3/pulmozyme.htm

Pulmozyme (Genentech Inc) fda sheet

Pulmozyme (Genentech Inc) msds (material safety sheet)

Pulmozyme (Genentech Inc) Synthesis Reference

No information avaliable

Pulmozyme (Genentech Inc) Molecular Weight

29253.9

Pulmozyme (Genentech Inc) Melting Point

67 oC (Chan, H.K. et al., Pharm Res. 13:756-761 (1996))

Pulmozyme (Genentech Inc) H2O Solubility

No information avaliable

Pulmozyme (Genentech Inc) State

Liquid

Pulmozyme (Genentech Inc) LogP

-0.083

Pulmozyme (Genentech Inc) Dosage Forms

Solution

Pulmozyme (Genentech Inc) Indication

For treatment of cystic fibrosis

Pulmozyme (Genentech Inc) Pharmacology

Cystic fibrosis (CF) is a disease characterized by the retention of viscous purulent secretions in the airways. These thick secretions contribute both to reduced pulmonary function and to frequent pulmonary infection. Purulent pulmonary secretions contain very high concentrations of extracellular DNA released by degenerating leukocytes that accumulate in response to these infections. Pulmozyme hydrolyzes the DNA in sputum of CF patients and reduces sputum viscoelasticity.

Pulmozyme (Genentech Inc) Absorption

No information avaliable

Pulmozyme (Genentech Inc) side effects and Toxicity

No information avaliable

Pulmozyme (Genentech Inc) Patient Information

BIOD00001.html

Pulmozyme (Genentech Inc) Organisms Affected

Humans and other mammals